Delivery Order SPE2DB20D2014-SPE2DB25FC61F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,300.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 24, 2025, with completion scheduled for July 25, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under the company's broader supply arrangement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract covers pharmaceutical delivery to support federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $2,733.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on a firm fixed-price basis. The award, made on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen will perform from its corporate office location in Conshohocken, Pennsylvania, fulfilling this pharmaceutical delivery order as part of the Defense...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,252.25 on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens (0.5 ml units). The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. This delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens valued at $1,801.80, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order, awarded on July 29, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $2,576.57. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC61FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,252.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed-price delivery order, which is not set aside for small businesses or other designated groups, represents a competitively awarded contract supporting the federal medical procurement needs of military and veteran healthcare systems. The award was performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. This prime contract vehicle enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio and proven capability to compete successfully for such awards demonstrate its established role as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/31/25 |